Hematology/Oncology Clinics of North America
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Key Metrics
Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
- PublisherW B SAUNDERS CO-ELSEVIER INC
- LanguageEnglish
- FrequencyBi-monthly
- LanguageEnglish
- FrequencyBi-monthly
- Publication Start Year1987
- Publisher URL
- Website URL
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Meets Top Publisher Standards: Essential for leading journals like Elsevier.Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
3000+ graphical abstracts produced with 4.8/5 customer rating Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Hematology/Oncology Clinics of North America been publishing? 
The Hematology/Oncology Clinics of North America has been publishing since 1987 till date.
How frequently is the Hematology/Oncology Clinics of North America published?
Hematology/Oncology Clinics of North America is published Bi-monthly.
Who is the publisher of Hematology/Oncology Clinics of North America?
The publisher of Hematology/Oncology Clinics of North America is W B SAUNDERS CO-ELSEVIER INC.
How can I view the journal metrics of Hematology/Oncology Clinics of North America on editage?
For the Hematology/Oncology Clinics of North America metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Hematology/Oncology Clinics of North America?
The eISSN number is 1558-1977 and pISSN number is 0889-8588 for Hematology/Oncology Clinics of North America.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Quality of life, Clinical investigation, Bladder cancer, Mantle cell lymphoma, Cell therapy, Myelofibrosis, Chronic pain, Immunotherapy, Hematopoietic stem cell transplantation, Bruton's tyrosine kinase inhibitor, Lung cancer, Paranasal sinus cancer, Hematopoietic stem cell, Follicular lymphoma, Initial treatment, Blastic plasmacytoid dendritic cell neoplasm, Urothelial carcinoma, Emergency department, Immune checkpoint inhibitors, Systemic amyloidosis.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.